Drugs / Medicines Recalls and Alerts |
 |
Ortho-Clinical Diagnostics Issues Class I Recall on Vitros Immunodiagnostic Products
Date: 5/1/2006
Reason: A decreased signal in the reagent may produce inaccurate results in some cases, affecting the outcome of the diagnostic tests. Distribution: Nationwide.
Need Legal Help?
Does this recall or safety alert affect you or your family?
|
The Food and Drug Administration (FDA) released the following information:
Class 1 Medical Device Recalls - Ortho-Clinical Diagnostics VITROS Immunodiagnostic Products Signal Reagent
Product: VITROS Immunodiagnostic Products Signal Reagent, Lot 8350, catalog #107 2693 VITROS Immunodiagnostic Products Signal Reagent, Lot 8530, catalog #107 2693 Use: This reagent is a special chemical used with the VITROS Immunodiagnostic ECi/ECiQ System to screen patient samples and diagnose more than 40 diseases and conditions including cardiac disease, hepatitis (A, B or C), thyroid disorders, HIV and pregnancy. Recalling Firm: Ortho-Clinical Diagnostics 100 Indigo Creek Dr Rochester , New York 14626-5101 Reason for Recall: A decreased signal in the reagent may produce inaccurate results in some cases, affecting the outcome of the diagnostic tests. Public Contact: Judy M. Strzepek Director, WW Quality Systems and Compliance Ortho-Clinical Diagnostics, Inc. 1001 U.S. Highway 202 Raritan, NJ 08869 908-218-8524 FDA District: New York Downstate FDA Comments: Customers with the affected lot numbers should discontinue using any remaining VITROS Immunodiagnostic Products Signal Reagent, Lot 8350 or 8530. Customers should follow the enhanced Quality Control (QC) procedure provided by Ortho-Clinical Diagnostic for each pack in all lots of VITROS Signal Reagent until further notice. Patients who have had diagnostic testing performed for any of these medical conditions within the last 60 days and are concerned with their test results should discuss them with their physicians: cardiac disease, hepatitis (A,B, or C), thyroid disorders, HIV and pregnancy. Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of the product will cause serious injury or death. A copy of Ortho-Clinical Diagnostics' (a Johnson & Johnson company) press release about this recall can be found on the company's website.
Type of Recall: Class I - This is a health hazard situation where there is a reasonable probability that the use of the product will cause serious, adverse health consequences or death.
Other Drugs / Medicines Recalls and Alerts of Interest
Date: 6/16/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate
Distribution: Nationwide
Date: 6/12/2008 Reason: it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil
Distribution: Nationwide
Date: 6/12/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate
Distribution: Nationwide
Date: 6/12/2008 Reason: Taking AZASAN® instead of SOLODYN® presents a health hazard and safety risk to patients
Distribution: Nationwide
Date: 6/12/2008 Reason: Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS)
Distribution: Nationwide
Date: 6/12/2008 Reason: Limited lots of Carmeda-coated products were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS).
Distribution: Nationwide
|